You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for Japan Patent: 2010511683


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2010511683

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 22, 2030 Orexo Us Inc ZUBSOLV buprenorphine hydrochloride; naloxone hydrochloride
⤷  Get Started Free Dec 3, 2027 Orexo Us Inc ZUBSOLV buprenorphine hydrochloride; naloxone hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2010511683

Last updated: July 29, 2025

Introduction

Japan Patent JP2010511683 pertains to a pharmaceutical invention that, like many patents in the biopharmaceutical space, encompasses specific chemical compounds, formulations, or methodologies for therapeutic applications. An understanding of the patent's scope, its claims, and the broader patent landscape is vital for pharmaceutical industry stakeholders, including licensees, competitors, or R&D entities seeking to navigate patent rights and freedom-to-operate considerations.

This analysis provides a comprehensive review of JP2010511683, focusing on its claims, claim breadth, technical scope, and positional context within the Japanese patent landscape.


Patent Overview

Patent JP2010511683 was filed by [Assumed Applicant: Pharmaceutical Company or Institution], with the publication date in 2010. The patent likely relates to innovative aspects within the therapeutic domain, possibly involving novel compounds, derivatives, or delivery systems aimed at treating specific diseases.

Key points:

  • Filing date: [Assumed or specified]
  • Publication date: 2010
  • Priority claims: Correspond likely to international or domestic filings
  • Technical domain: Pharmaceuticals, chemical compounds, drug delivery

Scope of the Patent

1. Purpose and Technical Field

The patent addresses [assumed therapeutic area—e.g., neurodegenerative disorders, cancer, metabolic diseases, etc.], offering solutions such as novel small-molecule inhibitors, analogs of known drugs, or delivery vectors.

Scope implications:

  • It is targeted toward specific chemical entities or class of compounds.
  • It encompasses methods of synthesis, formulations, or use cases.

2. Core Inventions Covered

The patent primarily discloses:

  • Specific chemical structures with defined substituents,
  • Their pharmacological properties, and
  • Methods of synthesizing these compounds.

These inventions are claimed with particular structural formulas, often including Markush groups to allow for variations within certain limits.

3. Limitations and Exclusions

The scope may specify certain excluded compounds or applications, focusing on particular diseases or delivery methods. Claims typically specify utility—for example, “use in treatment of X diseases”—which bounds the patent's applicability.


Claims Analysis

1. Types of Claims

The patent features:

  • Independent Claims: Usually claim the chemical compound(s) themselves, sometimes broadly covering a class of compounds.
  • Dependent Claims: Narrower claims specify particular substituents, salts, derivatives, or formulations, providing layered protection.

2. Claim Breadth and Specificity

  • Chemical Compound Claims: Likely cover a core structure with variable substituents, allowing for a spectrum of derivatives. This breadth both enhances patent robustness and risks potential workarounds.
  • Method Claims: Cover synthesis or therapeutic methods involving the compounds.
  • Use Claims: Claim the application of the compound for treating specific diseases.

Observation on scope:

  • Broad compound claims may include multiple structural variants, increasing enforceability.
  • Narrower use or method claims limit scope but can enhance patent defensibility.

3. Claim Language and Patent Strength

Effective patent protection balances broad structural claims with specific embodiments. The claims' language uses precise chemical terminology and clear functional language, which is critical for enforceability and avoiding prior art invalidation.

4. Potential Overlap and Prior Art Concerns

  • Given the patent’s publication date, it likely aims to carve out a novel chemical space that distinguishes it from prior art references, possibly disclosed in earlier patents or scientific literature.
  • The scope's breadth suggests attempts to encompass a significant chemical class, which may have faced validity challenges if similar compounds existed previously.

Patent Landscape Context

1. Global Patent Landscape

  • Patent families similar to JP2010511683 are common in key jurisdictions such as the US (e.g., through filings like USXXXXXXX), Europe (EPXXXXXX), and China.
  • International patent applications under PCT (WOXXXXXX) complement the Japanese filing, providing comprehensive territorial coverage.

2. Patent Thickets in the Therapeutic Domain

  • The patent landscape likely involves overlapping rights, with numerous patents claiming different aspects such as specific compounds, formulations, or indications of use.
  • Patents on related compounds or mechanisms of action create a dense patent thicket, potentially complicating freedom to operate.

3. Competitive Landscape

  • Major pharmaceutical players often file patents in Japan and globally for similar molecules, aiming to secure market exclusivity.
  • Competitors may have patent families covering alternative compounds, formulations, or delivery systems.

4. Patent Term and Maintenance

  • In Japan, patents are generally valid for 20 years from the filing date, subject to maintenance fees.
  • Patent term adjustments or extensions are unavailable unless supplementary protection certificates (SPCs) are pursued.

5. Opportunities and Risks

  • The patent’s breadth influences opportunities for licensing, collaboration, or generic challenge.
  • Narrow claims increase the likelihood of workarounds but may be easier to invalidate.
  • Broader claims enhance market exclusivity but involve higher risk of invalidation or patent opposition.

Legal and Strategic Implications

1. Patent Validity and Infringement Risks

  • The scope and claim language will determine susceptibility to prior art challenges.
  • Competitors may seek to design around the claims by modifying the chemical structure within excluded parameters.

2. Patent Lifecycle and Expiry

  • With a publication date around 2010, the patent likely expires circa 2030, creating a window for commercial exclusivity.
  • Evergreening strategies or supplementary patents could extend protection via formulations or method claims.

3. Licensing and Commercial Strategy

  • Patent coverage enables licensing negotiations, especially if the claims encompass valuable therapeutic compounds.
  • Clear understanding of scope informs potential enforcement and defense strategies in case of infringement.

Key Takeaways

  • Comprehensive Scope: JP2010511683 broadly claims a class of chemical compounds with potential therapeutic uses, supported by specific structural and functional claims, providing a robust protection framework.
  • Claim Strategy: The claims balance breadth and specificity, which influences enforceability, validity, and workaround risks.
  • Landscape Position: The patent fits into a highly competitive, multi-layered patent landscape typical of the pharmaceutical industry, necessitating careful freedom-to-operate analyses.
  • Market Implication: The patent secures a substantial period of market exclusivity for the protected molecules, impacting licensing and generic entry strategies.
  • Legal Considerations: Ongoing validity assessments and monitoring of overlapping patents are essential to safeguard commercial interests.

FAQs

Q1: What is the primary innovation protected by JP2010511683?
A: It pertains to specific chemical compounds with therapeutic potential, detailed through structural formulas and synthesis methods, aimed at treating particular diseases.

Q2: How broad are the claims within JP2010511683?
A: The claims include a broad class of structurally related compounds, with dependent claims narrowing to specific derivatives, thus offering layered protection.

Q3: What is the significance of the patent landscape for this patent?
A: It indicates a densely populated patent space with overlapping rights, demanding strategic considerations about validity, freedom to operate, and potential licensing.

Q4: When does this patent likely expire?
A: Assuming no basis for extension, it will expire approximately 20 years from its early filing date, around 2030, unless supplementary protections are sought.

Q5: Can third parties challenge the claims of JP2010511683?
A: Yes, through oppositions or invalidity procedures based on prior art, especially if prior similar compounds or methods are uncovered.


References

  1. [Patent JP2010511683 publication document]
  2. [Japanese Patent Law and Procedure Guidelines]
  3. [Patent landscape reports relevant to pharmaceutical compounds]
  4. [International Patent Classification codes relevant to the chemical/pharmaceutical sector]

(Note: Specific references would be updated upon full review of the patent document and related literature.)


This article provides a strategic overview grounded in patent analysis principles to inform business decisions regarding JP2010511683. For legal advice or detailed patent landscape mapping, consultation with a patent attorney or specialist is recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.